Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with BioMarin. We're very delighted to have BioMarin's new CEO, Alexander Hardy, making a presentation for the company. We're going to follow that with Q&A. If you're in the room, someone will bring you a mic, if you raise your hand for a question, you can also submit them over the portal or you can listen to me ask questions.
But with that, let me pass it over to Alexander.
Thanks very much, Jess. Good morning, everybody. As Jess said, I'm Alexander Hardy. I'm the new CEO of BioMarin. I started in the role, 1st of December 2023. Thank you very much for joining us here today. So this is our safe harbor statement. I'll be making forward-looking comments, so please look at our publicly available materials for more information.
So I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
